Journals / Experimental Biomedical Research / 2022 / Cilt: 5 - Sayı: 3

Evaluation of fatigue-related kinesiophobia and associated factors in individuals with lung cancer with and without respiratory comorbidity

Pages
319–329
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a difference between the pain and performance status of the individuals in the study in activities of daily living (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To investigate fatigue-related kinesiophobia and associated factors in individuals with lung cancer.
📊
Key Findings & Data:Methods: A total of 52 individuals were included in the study and the individuals were divided into two groups, each consisting of 26 individuals.
💡
Conclusion & Impact:There was a difference between the pain and performance status of the individuals in the study in activities of daily living (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To investigate fatigue-related kinesiophobia and associated factors in individuals with lung cancer. Methods: A total of 52 individuals were included in the study and the individuals were divided into two groups, each consisting of 26 individuals. Charlson comorbidity index, Brief Fatigue Inventory, modified Medical Research Council dyspnea scale, Tampa Kinesiophobia Scale-Fatigue are applied as data collection tools. Results: The individuals in the study had similar demographic characteristics. There was no difference between the groups in the study in terms of fatigue-related kinesiophobia. There was a difference between the pain and performance status of the individuals in the study in activities of daily living (p

🔖

Cite This Article

YUMİN, E. T., ÖZEL, A., KONUK, S., ÖZSARI, E. (2022). Evaluation of fatigue-related kinesiophobia and associated factors in individuals with lung cancer with and without respiratory comorbidity. Experimental Biomedical Research, Cilt: 5 - Sayı: 3, 319–329. https://ajindex.com/articles/512586

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Lucía A, Earnest C, Pérez M. Cancer–related fatigue: can exercise physiology assist oncologists? Lancet Oncol. 2003
  2. 4(10):616- 25. [2]Mystakidou K, Tsilika E, Parpa E, et al. Psychometric properties of the brief fatigue inventory in Greek patients with advanced cancer. J Pain Symptom Manage. 2008
  3. 36(4):367-73. [3]Wang XS, Giralt SA, Mendoza TR, et al. Clinical factors associated with cancerrelated fatigue in patients being treated for leukemia and non-Hodgkin’s lymphoma. J Clin Oncol. 2002
  4. 20(5):1319-28. [4]Montoya M, Fossella F, Palmer JL, et al. Objective evaluation of physical function in patients with advanced lung cancer: a preliminary report. J Palliat Med. 2006
  5. 9(2):309-16. [5]Lundberg MK, Styf J, Carlsson SG. A psychometric evaluation of the Tampa Scale for Kinesiophobia—from a physiotherapeutic perspective. Physiother Theory Pract. 2004
  6. 20(2):121-33. [6]Nijs J, De Meirleir K, Duquet W. Kinesiophobia in chronic fatigue syndrome: assessment and associations with disability. Arch Phys Med Rehabil. 2004
  7. 85(10):1586- 92. [7]Dabek J, Knapik A, Gallert-Kopyto W, et al. Fear of movement (kinesiophobia)–an underestimated problem in Polish patients at various stages of coronary artery disease. Ann Agric Environ Med. 2020
  8. 27(1):56-60. [8]Cai L, Liu Y, Xu H, et al. Incidence and risk factors of kinesiophobia after total knee arthroplasty in Zhengzhou, China: a crosssectional study. J Arthroplasty. 2018
  9. 33(9):2858-62. [9]Luque-Suarez A, Martinez-Calderon J, Falla D. Role of kinesiophobia on pain, disability and quality of life in people suffering from chronic musculoskeletal pain: a systematic review. Br J Sports Med. 2019
  10. 53(9):554- 59. [10]Zhao L, Leung L-H, Wang J, et al. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer. BMC Pulm Med. 2017
  11. 17(1):1-7. [11]Laor A, Tal S, Guller V, et al. The Charlson Comorbidity Index (CCI) as a mortality predictor after surgery in elderly patients. Am Surg. 2016
  12. 82(1):22-27. [12]Ganti AK, Siedlik E, Marr AS, et al. Predictive ability of Charlson comorbidity index on outcomes from lung cancer. Am J Clin Oncol. 2011
  13. 34(6):593-96. [13]Birim Ö, Maat A, Kappetein AP, et al. Validation of the Charlson comorbidity index in patients with operated primary nonsmall cell lung cancer. Eur J Cardiothorac Surg. 2003
  14. 23(1):30-34. [14]Çinar D, Yava A. Validity and reliability of functional assessment of chronic illness treatment-fatigue scale in Turkish patients